HIGHLIGHTS
- who: Louise Bjerkan from the National Institute of Allergy and of Health (NIH), United States , Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway, Jenner Institute, University of have published the article: APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell Responses, in the Journal: (JOURNAL)
- what: The authors report a novel vaccination strategy against the merozoite form of malaria. Intramuscular vaccination with scFvaMHCII-PfRH5DNL in this study induced significantly higher PfRH5FL-specific IgG1 levels as compared to non-targeted control . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.